Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronny Drapkin

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|December 17, 2013
Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigensKatharine M Esselen, Shu-Kay Ng, Yuanyuan Hua, et al.
Cancer Immunology Research|December 1, 2021
The SETDB1-TRIM28 Complex Suppresses Antitumor ImmunityJianhuang Lin, Dajiang Guo, Heng Liu, et al.
The American Journal of Surgical Pathology|July 3, 2015
GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital TractBrooke E Howitt, Megan M Emori, Ronny Drapkin, et al.
Nature Communications|June 28, 2020
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signalingMatthew Knarr, Rita A Avelar, Sreeja C Sekhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and functionArcangela De Nicolo, Mariella Tancredi, Grazia Lombardi, et al.
Gynecologic Oncology|December 18, 2013
Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasmsKevin M Elias, S Intidhar Labidi-Galy, Allison F Vitonis, et al.
Cancer Research|December 25, 2013
Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancersAlison M Karst, Paul M Jones, Natalie Vena, et al.
Gynecologic Oncology|March 18, 2008
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutationsAnn K Folkins, Elke A Jarboe, Aasia Saleemuddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer NanoparticleErik C Dreaden, Yi Wen Kong, Stephen W Morton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 3, 2014
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk womenBeth Y Karlan, Jason Thorpe, Kate Watabayashi, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|December 17, 2013
Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigensKatharine M Esselen, Shu-Kay Ng, Yuanyuan Hua, et al.
Cancer Immunology Research|December 1, 2021
The SETDB1-TRIM28 Complex Suppresses Antitumor ImmunityJianhuang Lin, Dajiang Guo, Heng Liu, et al.
The American Journal of Surgical Pathology|July 3, 2015
GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital TractBrooke E Howitt, Megan M Emori, Ronny Drapkin, et al.
Nature Communications|June 28, 2020
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signalingMatthew Knarr, Rita A Avelar, Sreeja C Sekhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and functionArcangela De Nicolo, Mariella Tancredi, Grazia Lombardi, et al.
Gynecologic Oncology|December 18, 2013
Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasmsKevin M Elias, S Intidhar Labidi-Galy, Allison F Vitonis, et al.
Cancer Research|December 25, 2013
Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancersAlison M Karst, Paul M Jones, Natalie Vena, et al.
Gynecologic Oncology|March 18, 2008
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutationsAnn K Folkins, Elke A Jarboe, Aasia Saleemuddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer NanoparticleErik C Dreaden, Yi Wen Kong, Stephen W Morton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 3, 2014
Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk womenBeth Y Karlan, Jason Thorpe, Kate Watabayashi, et al.
Pageof 18